• Skip to main content
Scientific Sessions
Scientific Sessions Conference Coverage logo
  • Program
  • #AHA25
Topics
  • Late-Breaking Science
  • Daily Coverage
  • Industry Highlights
  • Photo Gallery
  • Journeys
  • AHAtv
Resources
  • Program
  • #AHA25
User Tools
  • Privacy Policy
  • Terms & Conditions
  • Accessibility Statement
Twitter X icon Facebook iconInstagram iconYouTube iconPinterest iconLinkedIn icon
  • Late-Breaking Science
  • Daily Coverage
  • Industry Highlights
  • Photo Gallery
  • Journeys
  • AHAtv
Topics
  • Late-Breaking Science
  • Daily Coverage
  • Industry Highlights
  • Photo Gallery
  • Journeys
  • AHAtv
Resources
  • Program
  • #AHA25
User Tools
  • Privacy Policy
  • Terms & Conditions
  • Accessibility Statement
Twitter X icon Facebook iconInstagram iconYouTube iconPinterest iconLinkedIn icon
Nov 14th, 2020

AHA president: The best way forward requires bridging disciplines, people, places


Pres Session Elkind Bridge Close

The challenges facing our world are many — from timely concerns such as the coronavirus pandemic and the renewed emphasis it has placed on the need to dismantle structural racism to the ongoing challenges of treating and beating the top two killers around the globe: heart disease and stroke.

As president of the American Heart Association, Mitchell S.V. Elkind, MD, MS, FAHA, FAAN, sees the bridges linking these issues. He also believes solutions can emerge from those connections. He used bridges as the guiding metaphor of his Conner Lecture delivered Saturday during Scientific Sessions 2020.

“I believe building bridges can lead us from our current crises to the brighter and more hopeful future beyond,” said Dr. Elkind, professor of neurology and epidemiology at Columbia University in New York City. “The AHA has always been a leader in bridging seemingly disparate fields.”

Regarding the organization’s role in battling the novel coronavirus, Dr. Elkind drew a parallel to one of the organization’s first forays into the public health with the fight against rheumatic fever in the early to mid-1920s in the U.S. and Europe.

“Children suffering from rheumatic fever occupied almost a quarter of pediatric beds,” he said. “While doctors and nurses treated them, the AHA worked to educate and advocate for patients with the illness. The success of this public health campaign brought the incidence of rheumatic fever in the U.S. to nearly zero. It’s remarkable that even before penicillin, we were able to stifle a grave infectious danger. The AHA’s role at that time surely ranks among our greatest contributions to public health.”

One of the AHA’s top efforts in the pandemic was creating the COVID-19 Cardiovascular Disease Registry powered by Get With The Guidelines. Dr. Elkind is on its steering committee.

He also played a lead role in crafting the AHA presidential advisory released Tuesday. Titled “Call to Action: Structural Racism as a Fundamental Driver of Health Disparities,” it was published in the AHA’s journal Circulation. Dr. Elkind reinforced its points in his address Saturday.

“The disparities and inequities made manifest by the virus were clear before the crisis struck,” he said. “The AHA has long worked to address the social determinants of health — because your ZIP code shouldn’t determine how long or how well you live. The health of the least fortunate has implications for all of society. Issues that previously seemed unrelated to health care and medical science are now increasingly recognized as crucial bridges to our success: quality education, workplace health and safety, affordable and safe housing, air quality, and more.”

Dr. Elkind described his path to the presidency, showing how early influences — such as studying John Dewey and studying and meeting Dr. Oliver Sacks — shaped his journey and his views.

He appreciated how Dewey upended conventional wisdom of his era by emphasizing “practice and application over rote memorization.”

 “Dewey’s pragmatic way of thinking — looking for the commonalities in areas where they weren’t apparent — appealed to me as a student, and still does as a physician,” he said.

Dr. Elkind first got to know Sacks through his books, such as “Awakenings” and “The Man Who Mistook His Wife for a Hat.” Yet, to Dr. Elkind, Sacks was more than a leading thinker; he’d trained as a fellow alongside Dr. Elkind’s father. This led to Dr. Elkind, early in his career, sitting next to Sacks at a gala dinner, an evening Dr. Elkind called “the neurologist’s equivalent of playing catch with Willie Mays.”

“What thrilled me about neurology was what Oliver Sacks so beautifully depicted: the stories our patients tell; and how their illnesses, like aphasia and apraxia, intertwine with their lives, in a sense becoming their lives, for there is no other way for them to experience the world,” Dr. Elkind said. “My own teachers and mentors shared that passion for understanding the relationship between neurological disease and human experience.”

Dr. Elkind arrived at Columbia for his own fellowship. Working with Dr. Ralph Sacco, Dr. Elkind expanded his focus to include epidemiology. (Dr. Sacco would go on to become the first neurologist to serve as AHA president; Dr. Elkind is the second.) He then began studying the role of infections in neurology, a subject that has dramatically become more urgent in recent months.

“In the midst of this global coronavirus pandemic, the hypothesis that infections trigger cerebrovascular disease has grown even more pressing,” he said. “This virus, SARS-CoV-2, spurs us to build yet more bridges among infectious disease, cardiovascular disease and cerebrovascular illness. To consider our specialized fields separated by barriers is as unwarranted as the false dichotomy between education and practice that Dewey criticized. In fact, intellectual historians have found that the greatest innovation and discoveries occur in the intersection between fields.”

Another bridge he highlighted is the growing evidence that “brain failure, akin to heart failure” is “responsible for the slow progressive decline in function seen in many of us as we age.”

“As a result, the notion that neurodegenerative diseases exist completely apart from vascular disease has been seriously challenged,” he said. “Increasingly, evidence has shown that vascular risk factors, like hypertension, diabetes, obesity, and atrial fibrillation, are related to cognitive decline and dementia, and in particular to Alzheimer’s disease. We are, in other words, beginning to cross the bridges that connect the vascular and the neurodegenerative.”

Dr. Elkind noted that the pandemic has revealed an ailing global nervous system.

“Some of our most stable bridges have begun to sway; we can’t afford to let them fall,” he said.

The solution, he said, could come from merging specialized areas of knowledge.

“To improve cardiovascular health, we have many bridges to build among medical disciplines, and others we need to strengthen, like the links connecting the scientific and medical community to our leaders and the public, and those among all countries,” he said

Dr. Elkind said the AHA strives to be one of those conveners.

“It’s critical that we and all our partners around the globe strive to build these bridges, strengthen the links among communities, foster cooperation and collaboration among those seeking progress, and work to create a more just and healthy society,” he said. “I invite each of you to help us build and cross these bridges to a better future.”

Interesting Stories
Advancing Maternal Health: Closing the Gaps in Cardiovascular Care
Sponsored by K.A.H.R Foundation
Advancing Maternal Health: Closing the Gaps in Cardiovascular Care
Lp(a): A Toolkit for Health Care Professionals
Sponsored by Novartis Pharmaceuticals Corporation
Lp(a): A Toolkit for Health Care Professionals
Join our presentation about severe hypertriglyceridemia (sHTG)
Sponsored by Ionis Pharmaceuticals
Join our presentation about severe hypertriglyceridemia (sHTG)
More Content
Getty Images 2164112950
Daily Coverage
Help us improve Scientific Sessions
Nov 13th, 2025
Getty Images 108271249
Daily Coverage
Save the date and meet us in Chicago
Nov 12th, 2025
Getty Images 1773071954
Daily Coverage
Get Scientific Sessions OnDemand
Nov 12th, 2025
Ahass25 Audience8
Daily Coverage
Cutting-edge valve and coronary trials
Nov 10th, 2025
Ahass25 Audience1
Late-Breaking Science
Cardiometabolic and lifestyle interventions for AFib
Nov 9th, 2025
Ardem Patapoutian, PhD
Daily Coverage
Ardem Patapoutian, PhD, delivers Nobel Laureate lecture
Nov 9th, 2025
From left: JoAnn Lindenfeld, MD, Philippe Pibarot, DVM, PhD, FAHA
Home
Heart care through a mature lens
Nov 9th, 2025
Susan R. Davis, PhD, AO, MBBS, FRACP, FAHMS
Daily Coverage
Health, happiness and hormones
Nov 9th, 2025
From left: Marc Ruel, MD, MPH, Michelle O’Donoghue, MD, MPH
Daily Coverage
Acute coronary syndromes guideline gets overhaul
Nov 9th, 2025
Christopher Long, PhD
Daily Coverage
Food for thought — and health
Nov 9th, 2025
Miguel Leal, MD
Daily Coverage
Innovations in cardiac electrophysiology take center stage at joint session
Nov 9th, 2025
Erin Poe Ferranti, PhD, MPH, RN, FAHA, FPCNA, FAAN
Home
Nursing trailblazers advance cardiovascular prevention and management strategies
Nov 9th, 2025